Document is current
Any future updates will be listed below
-
Authors
Mueller, Gloria
Zatcepin, Artem
Bartos, Laura M.
Hoermann, Leonie
Wesser, Lena
Park, Ha Eun
Thevis, Justus F.
Haertel, Marlies
Kunze, Lea H.
Palumbo, Giovanna
Kolabas, Zeynep Ilgin
Lindner, Simon
Werner, Rudolf A.
Albert, Nathalie L.
von Baumgarten, Louisa
Ziegler, Sibylle
Brendel, Matthias https://orcid.org/0000-0002-9247-2843
-
Funding
Funding for this research was provided by:
Klinikum der Universität München
- License Information
-
More Information
Article History
Received: 26 March 2026
Accepted: 2 July 2026
First Online: 14 July 2026
Change Date: 25 July 2026
Change Type: Update
Change Details: The article was modified to replace the incorrect supplementary file.
Declarations
Ethics approval: All animal experiments were performed according to the National Guidelines for Animal Protection, Germany, with the approval of the regional animal committee (Regierung von Oberbayern) and under the supervision of a veterinarian.
Competing interests: MB has received speaking fees from Roche, GE Healthcare, and Life Molecular Imaging, is a consultant for Life Molecular Imaging, and is a member of the EANM Neuroimaging Committee. NLA has received honoraria for lectures, consultation, or advisory board participation from ABX, Advanced Accelerator Applications, Carthera, Crinetics, ITM Oncologics GmbH, Medsir, Novartis, OncLive, Servier and Telix Pharmaceuticals, and research funding from Novocure, Telix Pharmaceuticals, and Servier. RAW reports advisory board work for and has received speaker honoraria from Novartis. GM, AZ, LMB, LH, LW, HEP, JFT, MH, GP, LHK, SL, LvB, SZ, and ZIK declare that they have no competing interests.
